<DOC>
	<DOCNO>NCT01545050</DOCNO>
	<brief_summary>The purpose study characterize safety , efficacy dose response BMS-945429 subject moderate severe Crohn 's disease insufficient response conventional therapy fail Anti-Tumor Necrosis Factor ( anti-TNF ) therapy .</brief_summary>
	<brief_title>Dose Ranging Study BMS-945429 Subjects With Moderate Severe Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Confirmed Crohn 's Disease diagnosis via radiology , endoscopy histology within prior 12 month . Diagnosed least 3 month Active Disease Crohn 's Disease Activity Index ( CDAI ) ≥ 220 ≤ 450 Failed conventional therapy steroid dependent Diagnosed/clinical finding Ulcerative Colitis ( UC ) , indeterminate colitis , non colonic/ileal disease Stricture/stenosis , Stoma , proctocolectomy , subtotal colectomy , ileorectal anastomosis History diverticulitis , evidence Gastrointestinal ( GI ) perforation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>